Suicidal ideation and thought disorder associated with the formoterol component of combined asthma medication1. Issue 1 (9th April 2012)

• Record Type: Journal Article
• Authors: del Rosario, Mary Anne; Bender, Bruce G.; White, Carl W.
• Is Part Of: Pediatric pulmonology. Volume 48:Issue 1(2013:Jan.)
• Page Start: 102
• Page End: 103
• Publication Date: 2012-04-09
• Subjects: Pediatric respiratory diseases -- Periodicals; Pediatrics -- Periodicals; 618.922
• DOI: 10.1002/ppul.22563
• Languages: English
• ISSNs: 8755-6863

Abstract

<abstract abstract-type="main" xml:lang="en"> <title>Abstract</title> <p>Combination inhaled asthma medications containing corticosteroids and long‐acting beta‐adrenergic (LABA) agents are generally well tolerated, although a small minority of children receiving them may develop side‐effects. Herein is reported a case of a 9‐year‐old boy who developed insomnia, pressured speech, agitation, and suicidal ideation within the 1st month after initiating formoterol + budesonide. He had not received oral glucocorticoids for &gt;90 days. All symptoms resolved within 48 hr upon discontinuing formoterol while continuing budesonide. To our knowledge, this is the first report of childhood suicidal ideation strongly associated with use of a combination inhaled corticosteroid/LABA. Pediatr Pulmonol. 2013; 48:102–103. © 2012 Wiley Periodicals, Inc.</p> </abstract>